ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 82 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2014. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,759,026 | -18.4% | 189,594 | +5.6% | 0.00% | -25.0% |
Q2 2023 | $8,285,779 | +15.1% | 179,618 | +0.1% | 0.00% | 0.0% |
Q1 2023 | $7,197,629 | -14.2% | 179,492 | -0.9% | 0.00% | 0.0% |
Q4 2022 | $8,389,992 | +13.6% | 181,092 | +1.5% | 0.00% | 0.0% |
Q3 2022 | $7,386,000 | -30.9% | 178,363 | -0.5% | 0.00% | -20.0% |
Q2 2022 | $10,691,000 | -17.8% | 179,197 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $13,013,000 | -13.6% | 179,197 | -0.0% | 0.01% | 0.0% |
Q4 2021 | $15,070,000 | -17.5% | 179,211 | -11.5% | 0.01% | -28.6% |
Q3 2021 | $18,260,000 | -5.4% | 202,461 | +0.0% | 0.01% | 0.0% |
Q2 2021 | $19,298,000 | -16.3% | 202,385 | -0.0% | 0.01% | -22.2% |
Q1 2021 | $23,048,000 | -34.5% | 202,427 | -20.3% | 0.01% | -40.0% |
Q4 2020 | $35,172,000 | +11.8% | 254,078 | -33.6% | 0.02% | 0.0% |
Q3 2020 | $31,464,000 | -0.8% | 382,827 | +0.1% | 0.02% | -6.2% |
Q2 2020 | $31,726,000 | +86.7% | 382,473 | 0.0% | 0.02% | +45.5% |
Q1 2020 | $16,993,000 | +7.3% | 382,473 | +3.2% | 0.01% | +37.5% |
Q4 2019 | $15,830,000 | +154.4% | 370,650 | +154.8% | 0.01% | +166.7% |
Q3 2019 | $6,222,000 | -71.6% | 145,450 | -32.1% | 0.00% | -70.0% |
Q2 2015 | $21,942,000 | +64.9% | 214,300 | 0.0% | 0.01% | +66.7% |
Q1 2015 | $13,306,000 | +41.5% | 214,300 | 0.0% | 0.01% | +50.0% |
Q4 2014 | $9,403,000 | -24.8% | 214,300 | -2.9% | 0.00% | -33.3% |
Q3 2014 | $12,497,000 | +14.5% | 220,800 | -9.2% | 0.01% | +20.0% |
Q2 2014 | $10,913,000 | -8.2% | 243,100 | 0.0% | 0.01% | -16.7% |
Q1 2014 | $11,885,000 | – | 243,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |